Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Q&As

telehealth
Q&As
The Benefits and Challenges of Telehealth for Clinicians and Patients
06/14/2021
Researchers discuss the main takeaways from their recent virtual APA session as well as the primary challenges for both clinicians and patients when utilizing telehealth services. 
Researchers discuss the main takeaways from their recent virtual APA session as well as the primary challenges for both clinicians and patients when utilizing telehealth services. 
Researchers discuss the main...
06/14/2021
Psych Congress Network

Advertisement

Dr. Avrim Fishkind: Moving Beyond the Basics of Telepsychiatry
Q&A
Dr. Avrim Fishkind: Moving Beyond the Basics of Telepsychiatry
04/20/2021
A session being presented at the virtual 2021 American Psychiatric Association Annual Meeting will explore equity and ethical issues related to the practice and examine the future of telemedicine, including an array of digital tools.
A session being presented at the virtual 2021 American Psychiatric Association Annual Meeting will explore equity and ethical issues related to the practice and examine the future of telemedicine, including an array of digital tools.
A session being presented at the...
04/20/2021
Psych Congress Network
Kaftarian
Q&As
A Primer on Telehealth and Medical Licensing
04/13/2021
In this installment of "Your Questions Answered," Psych Congress Steering Committee member Edward Kaftarian, MD, responds to questions about your medical license and telehealth.
In this installment of "Your Questions Answered," Psych Congress Steering Committee member Edward Kaftarian, MD, responds to questions about your medical license and telehealth.
In this installment of "Your...
04/13/2021
Psych Congress Network
Upasana Bondopadhyay, MPhil
Q&As
Managing Sleep Problems Could Improve Overall Outcomes in Youth With ADHD
03/26/2021
(Part 2 of 2) Successfully managing sleep problems in children with attention-deficit/hyperactivity disorder (ADHD) may help improve behavioral and cognitive outcomes, according to authors of a systematic review recently published in the...
(Part 2 of 2) Successfully managing sleep problems in children with attention-deficit/hyperactivity disorder (ADHD) may help improve behavioral and cognitive outcomes, according to authors of a systematic review recently published in the...
(Part 2 of 2) Successfully...
03/26/2021
Psych Congress Network

Advertisement

child sleeping
Q&As
Dissecting the Role of Sleep Disturbances in Children With ADHD
03/04/2021
(Part 1 of 2)
(Part 1 of 2)
(Part 1 of 2)
03/04/2021
Psych Congress Network
Clozapine Treatment May Reduce Glutamate Levels in Caudate Nucleus
Q&As
Clozapine Treatment May Reduce Glutamate Levels in Caudate Nucleus
01/25/2021
Alice Egerton, PhD, discusses a study which found that symptom improvements in people with treatment-resistant schizophrenia who switch to clozapine may be related to reductions in glutamate in the caudate nucleus.
Alice Egerton, PhD, discusses a study which found that symptom improvements in people with treatment-resistant schizophrenia who switch to clozapine may be related to reductions in glutamate in the caudate nucleus.
Alice Egerton, PhD, discusses a...
01/25/2021
Psych Congress Network
Kaftarian
Q&A
Prescribing Controlled Substances When Using Telepsychiatry
12/10/2020
Learn how clinicians can navigate the federal limitation on prescribing controlled substances when treating patients outside of an authorized health care setting.
Learn how clinicians can navigate the federal limitation on prescribing controlled substances when treating patients outside of an authorized health care setting.
Learn how clinicians can...
12/10/2020
Psych Congress Network

Advertisement

Q&As
Managing Weight Gain in Patients With Schizophrenia
11/11/2020
Christoph Correll, MD, and Sanjai Rao, MD, respond to questions asked by attendees of a Psych Congress 2020 session they presented on managing weight gain and metabolic disruptions in patients with schizophrenia.
Christoph Correll, MD, and Sanjai Rao, MD, respond to questions asked by attendees of a Psych Congress 2020 session they presented on managing weight gain and metabolic disruptions in patients with schizophrenia.
Christoph Correll, MD, and...
11/11/2020
Psych Congress Network
New Practice Guidelines Aim to Reduce Harmful Consequences of Schizophrenia
Q&As
New Practice Guidelines Aim to Reduce Harmful Consequences of Schizophrenia
10/21/2020
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
Laura J. Fochtmann, MD, MBI,...
10/21/2020
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use